Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
EDP-323 by Enanta Pharmaceuticals for Respiratory Syncytial Virus (RSV) Infections: Likelihood of Approval
EDP-323 is under clinical development by Enanta Pharmaceuticals and currently in Phase I for Respiratory Syncytial Virus (RSV) Infections. According...
IVXA-12 by Icosavax for Respiratory Syncytial Virus (RSV) Infections: Likelihood of Approval
IVXA-12 is under clinical development by Icosavax and currently in Phase II for Respiratory Syncytial Virus (RSV) Infections. According to...
BLB-201 by Blue Lake Biotechnology for Respiratory Syncytial Virus (RSV) Infections: Likelihood of Approval
BLB-201 is under clinical development by Blue Lake Biotechnology and currently in Phase II for Respiratory Syncytial Virus (RSV) Infections....